Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting
Bruland P, Mcgilchrist M, Zapletal E, Acosta D, Proeve J, Askin S, Ganslandt T, Doods J, Dugas M (2016)
Publication Type: Journal article
Publication year: 2016
Journal
Publisher: BioMed Central Ltd.
Book Volume: 16
Pages Range: 159-168
URI: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118882/
DOI: 10.1186/s12874-016-0259-3
Authors with CRIS profile
Involved external institutions
Westfälische Wilhelms-Universität (WWU) Münster
Germany (DE)
University College London (UCL)
United Kingdom (GB)
Novartis AG
Switzerland (CH)
Georges Pompidou European Hospital / Hôpital Européen Georges-Pompidou (HEGP)
France (FR)
University of Dundee
United Kingdom (GB)
Germany (DE)
University College London (UCL)
United Kingdom (GB)
Novartis AG
Switzerland (CH)
Georges Pompidou European Hospital / Hôpital Européen Georges-Pompidou (HEGP)
France (FR)
University of Dundee
United Kingdom (GB)
How to cite
APA:
Bruland, P., Mcgilchrist, M., Zapletal, E., Acosta, D., Proeve, J., Askin, S.,... Dugas, M. (2016). Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting. Bmc Medical Research Methodology, 16, 159-168. https://doi.org/10.1186/s12874-016-0259-3
MLA:
Bruland, Philipp, et al. "Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting." Bmc Medical Research Methodology 16 (2016): 159-168.
BibTeX: Download